Opioid Use, Abuse and Misuse Resource Center

APhA believes it is imperative that a proper balance be maintained in delivering appropriate pain management for the millions of patients with legitimate needs for controlled substances while taking steps to minimize inappropriate use and abuse.  Pharmacists possess unique knowledge about the safe and effective use of medications and about the adverse events resulting from inappropriate use. Such knowledge enables pharmacists to play an important role in patient access to opioids, but also opioid drug abuse prevention, education, and assistance.  

Opioid News
July 10, 2018
Patients can get—and pharmacists can provide—naloxone at the pharmacy. Why don’t they?

Several major chains have trained all their pharmacists on naloxone. Forty-eight states and Washington, DC, allow pharmacists to dispense naloxone without a physician’s prescription. Access to naloxone through pharmacists is a win for the pharmacy profession—the role pharmacists could play in…

Read More
June 4, 2018
Post-procedure opioid-related ADEs deadly and costly

More than 10% of adults who undergo surgical or endoscopic procedures and receive opioids will have an opioid-related adverse drug event (ADE), according to a study published online in JAMA Surgery. Moreover, these adverse events were associated with an increased likelihood of poor outcomes. Using…

Read More
May 24, 2018
Opioid duration, not dosage, counts after surgery in reducing misuse

Prescription opioid duration—not the dosage—is associated with an increase in opioid misuse among postsurgical patients who were opioid-naive, according to results of a retrospective, observational study published in BMJ. These results suggest that opioid-naive patients who undergo surgery should…

Read More
May 16, 2018
Opioid summit brings together stakeholders, offers takeaway points

The opioid epidemic continues to affect families, communities, and the nation, and should remain a priority. That’s the main message from this year’s National Rx Drug Abuse & Heroin Summit on April 2–5, held annually in Atlanta for all stakeholders. “Seeing and hearing from the variety of…

Read More
April 13, 2018
Pharmacists’ services and H.R. 592 noted at House opioid hearing

Members of Congress, CMS, and health care leaders noted pharmacists’ services and H.R. 592 during the House Energy & Commerce Committee’s final hearing on April 11–12 that focused on improving Medicare and Medicaid for patients amidst the nation’s opioid crisis. The Senate Finance Committee…

Read More
March 27, 2018
Congressional focus on opioids is an opportunity for pharmacists and their patients

Opioids remain a policy priority for the U.S. Congress, with a package of bills known as “CARA 2.0” under consideration and relevant committees holding hearings on the issue. As these conversations evolve, pharmacists are expressing current and potential contributions to these efforts. Pharmacists…

Read More